Cooper Companies COO
NASDAQ COO
$76.22 +0.06 (+0.08%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cooper Companies (COO) Non-Current Deffered Revenue (2021 - 2026)

Cooper Companies (COO) posted quarterly Non-Current Deffered Revenue of $208.8 million for Q2 2026, up 6.31% year-over-year from $196.4 million in Q2 2025, and up 1.16% quarter-over-quarter from $206.4 million in Q1 2026.

Cooper Companies (COO) Non-Current Deffered Revenue (2021 - 2026) Analysis & Trends

Cooper Companies' Non-Current Deffered Revenue history runs 6 years deep, the most recent figure standing at $208.8 million for Q2 2026.

  • In Q2 2026, Non-Current Deffered Revenue rose 6.31% year-over-year to $208.8 million; the TTM figure through Apr 2026 stood at $208.8 million (up 6.31% YoY), while the FY2025 annual figure was $201.8 million, up 4.4% from the prior year.
  • Non-Current Deffered Revenue for Q2 2026 stood at $208.8 million, up from $206.4 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $208.8 million in Q2 2026, with the low at $182.6 million in Q2 2023.
  • The 5-year median for Non-Current Deffered Revenue is $193.4 million (2025), against an average of $194.1 million.
  • The sharpest annual moves came in 2022 and 2023: Non-Current Deffered Revenue surged 198200.0% in 2022, then decreased 7.11% in 2023.
  • Cooper Companies' Non-Current Deffered Revenue stood at $198.3 million in 2022, then fell by 7.11% to $184.2 million in 2023, then climbed by 4.94% to $193.3 million in 2024, then gained by 4.4% to $201.8 million in 2025, then advanced by 3.47% to $208.8 million in 2026.
  • Business Quant data shows COO's Non-Current Deffered Revenue at $208.8 million in Q2 2026, $206.4 million in Q1 2026, and $201.8 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 170.95 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 13.90 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 208.80 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -
10 Align Technology 11.61 Bn 10.51 Bn 757.43 Mn -

Historic Data

Download Data
DateValue
Apr 30, 2026 208.80 Mn
Jan 31, 2026 206.40 Mn
Oct 31, 2025 201.80 Mn
Jul 31, 2025 199.40 Mn
Apr 30, 2025 196.40 Mn
Jan 31, 2025 193.40 Mn
Oct 31, 2024 193.30 Mn
Jul 31, 2024 190.80 Mn
Apr 30, 2024 188.60 Mn
Jan 31, 2024 186.30 Mn
Oct 31, 2023 184.20 Mn
Jul 31, 2023 185.50 Mn
Apr 30, 2023 182.60 Mn
Jan 31, 2023 195.10 Mn
Oct 31, 2022 198.30 Mn
Oct 31, 2021 100,000.00